|
Implementation of universal, pan-cancer germline genetic testing in patients with cancer in Jordan. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Invitae |
|
|
|
Stock and Other Ownership Interests - InVitae |
Consulting or Advisory Role - InVitae |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - Genome Medical; Invitae; Maze Therapeutics |
|
Consulting or Advisory Role - Genome Medical; Maze Therapeutics; Pfizer |
Patents, Royalties, Other Intellectual Property - Royalties on a patented mouse model for Parkinson disease held by the National Institutes of Health and the University of California San Francisco |
|
|
|
Stock and Other Ownership Interests - Invitae |